136 related articles for article (PubMed ID: 18817665)
1. Focal myocardial uptake in a patient with carcinoid tumor by indium-111-pentetreotide on SPECT/CT.
Mahmood S; Martínez de Llano SR; Grewal RK
Rev Esp Med Nucl; 2008; 27(5):355-7. PubMed ID: 18817665
[TBL] [Abstract][Full Text] [Related]
2. Indium-111 pentetreotide imaging of carcinoid tumor of the thymus.
Borrero CG; McCook B; Mountz JM
Clin Nucl Med; 2005 Apr; 30(4):218-21. PubMed ID: 15764874
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular myocardial uptake of a labeled somatostatin analog in carcinoid syndrome.
Mure A; Lebtahi R; Sarda L; Glikmanas M; Cadiot G; Brochet E; Faraggi M; Le Guludec D
J Nucl Med; 1996 Feb; 37(2):275-8. PubMed ID: 8667061
[TBL] [Abstract][Full Text] [Related]
4. Visualization of myocardial metastasis of carcinoid tumor by indium-111-pentetreotide.
Yeung HW; Imbriaco M; Zhang JJ; Macapinlac H; Goldsmith SJ; Larson SM
J Nucl Med; 1996 Sep; 37(9):1528-30. PubMed ID: 8790210
[TBL] [Abstract][Full Text] [Related]
5. Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.
Macfarlane D; Gonin J; Wieland D; Mangner T; Froelich J; Beierwaltes W; Shapiro B
Eur J Nucl Med; 1996 Feb; 23(2):131-40. PubMed ID: 8925846
[TBL] [Abstract][Full Text] [Related]
6. Per operative localization of a carcinoid tumour of the breast using indium-111 pentetreotide and a nuclear surgical probe.
Meunier B; Le Cloirec J; Dazord L; Leveque J; Lesimple T; Tas P; Bourguet P
Eur J Nucl Med; 1995 Mar; 22(3):281-3. PubMed ID: 7789401
[TBL] [Abstract][Full Text] [Related]
7. Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue.
Dörr U; Räth U; Sautter-Bihl ML; Guzman G; Bach D; Adrian HJ; Bihl H
Eur J Nucl Med; 1993 May; 20(5):431-3. PubMed ID: 8100192
[TBL] [Abstract][Full Text] [Related]
8. Combined diagnostic imaging with 131I-metaiodobenzylguanidine and 111In-pentetreotide in carcinoid tumours.
Taal BG; Hoefnagel CA; Valdés Olmos RA; Boot H
Eur J Cancer; 1996 Oct; 32A(11):1924-32. PubMed ID: 8943676
[TBL] [Abstract][Full Text] [Related]
9. Scintiscans and carcinoid tumors.
Carnaille B; Nocaudie M; Pattou F; Huglo D; Deveaux M; Marchandise X; Proye C
Surgery; 1994 Dec; 116(6):1118-21; discussion 1121-2. PubMed ID: 7985096
[TBL] [Abstract][Full Text] [Related]
10. Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report.
Lobrano MB; McCarthy K; Adams L; Neitzschman H
Am J Gastroenterol; 1997 Mar; 92(3):513-5. PubMed ID: 9068482
[TBL] [Abstract][Full Text] [Related]
11. [Imaging of somatostatin receptor using 111In-pentetreotide].
Kimura T; Sakahara H; Higashi T; Honda T; Konishi J; Hosotani R; Oshio G; Imamura M; Inokuma T
Kaku Igaku; 1996 Apr; 33(4):447-52. PubMed ID: 8683886
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin-receptor scintigraphy of subcutaneous and thyroid metastases from bronchial carcinoid.
Krausz Y; Pfeffer MR; Glaser B; Lafair J
J Nucl Med; 1996 Sep; 37(9):1537-9. PubMed ID: 8790214
[TBL] [Abstract][Full Text] [Related]
13. Differentiation between carcinoid and sarcoid with F-18 FDG PET and In-111 pentetreotide.
Avram AM; Mackie GC; Schneider BJ; Kalemkerian GP; Shulkin BL
Clin Nucl Med; 2006 Apr; 31(4):197-200. PubMed ID: 16550010
[TBL] [Abstract][Full Text] [Related]
14. Intraoperative detection of a bronchial carcinoid with a radiolabeled somatostatin analog.
Rodriguez JA; Meyers MO; Jacome TH; Failla P; Harrison LH
Chest; 2002 Mar; 121(3):985-8. PubMed ID: 11888987
[TBL] [Abstract][Full Text] [Related]
15. Imaging of bronchial carcinoid tumours with indium-111 pentetreotide.
O'Byrne KJ; O'Hare NJ; Freyne PJ; Luke DA; Clancy LJ; Prichard JS; Carney DN
Thorax; 1994 Mar; 49(3):284-6. PubMed ID: 7911261
[TBL] [Abstract][Full Text] [Related]
16. SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors.
Schillaci O; Scopinaro F; Angeletti S; Tavolaro R; Danieli R; Annibale B; Gualdi G; Delle Fave G
J Nucl Med; 1996 Sep; 37(9):1452-6. PubMed ID: 8790191
[TBL] [Abstract][Full Text] [Related]
17. Whole body and tomographic scan with 111In-pentetreotide: preliminary data.
Gregianin M; Macrì C; Bui F; Varotto L; Zucchetta P
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):124-6. PubMed ID: 9002769
[TBL] [Abstract][Full Text] [Related]
18. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of octreotide in the regression of a metastatic carcinoid tumour despite negative imaging with In-111-pentetreotide (Octreoscan).
Hillman N; Herranz L; Alvarez C; Martínez Olmos MA; Márco A; Gómez-Pan A
Exp Clin Endocrinol Diabetes; 1998; 106(3):226-30. PubMed ID: 9710364
[TBL] [Abstract][Full Text] [Related]
20. Comment on primary localization of an ectopic ACTH-producing bronchial carcinoid tumor by indium111 pentetreotide scintigraphy.
Reincke M; Allolio B; Arlt W; Körber C
J Clin Endocrinol Metab; 1999 Sep; 84(9):3399-400; author reply 3402-3. PubMed ID: 10487718
[No Abstract] [Full Text] [Related]
[Next] [New Search]
